Objective: To investigate the effect of antioxidant supplementation on viral load and the antioxidantareactive oxygen species system in people with HIV. Design: Single centre, prospective, dose comparison study. Setting: Outpatient clinic specializing in HIV care. Subjects: Sixty-six participants were sequentially recruited by advertisement, and 48 subjects completed the study. Interventions: A recommended dose antioxidant regimen (5450 IU vitamin A as b-carotene, 250 mg vitamin C, 100 IU vitamin E, 100 mg selenium, 50 mg coenzyme Q10) or a high-dose antioxidant regimen (21 800 IU vitamin A as b-carotene, 1000 mg vitamin C, 400 IU vitamin E, 200 mg selenium, 200 mg coenzyme Q10) for a 12 week period. Results: Using repeated measures analysis of variance, the changes over treatment time were signi®cant for selenium, glutathione, glutathione peroxidase and lipid peroxides (P`0.03). Changes in allantoin, uric acid and viral load were not signi®cant (Pb0.05). The main effects for group and the interaction effects were not signi®cant for any of the parameters measured (P ! 0.05).